Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells  by Fanzani, A. et al.
Overexpression of cytosolic sialidase Neu2 induces myoblast
di¡erentiation in C2C12 cells
A. Fanzania;, R. Giuliania, F. Colomboa, D. Ziziolia, M. Prestab, A. Pretia, S. Marchesinia
aUnit of Biochemistry, Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy
bUnit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy
Received 7 May 2003; revised 5 June 2003; accepted 9 June 2003
First published online 26 June 2003
Edited by Veli-Pekka Lehto
Abstract Cytosolic sialidase Neu2 has been implicated in myo-
blast di¡erentiation. Here we observed a signi¢cant upregula-
tion of Neu2 expression during di¡erentiation of murine C2C12
myoblasts. This was evidenced both as an increase in Neu2
mRNA steady-state levels and in the cytosolic sialidase enzy-
matic activity. To understand the biological signi¢cance of Neu2
upregulation in myoblast di¡erentiation, C2C12 cells were sta-
bly transfected with the rat cytosolic sialidase Neu2 cDNA.
Neu2 overexpressing clones were characterized by a marked
decrement of cell proliferation and by the capacity to undergo
spontaneous myoblast di¡erentiation also when maintained
under standard growth conditions. This was evidenced by the
formation of myogenin-positive myotubes and by a signi¢cant
decrease in the nuclear levels of cyclin D1 protein. No di¡er-
entiation was on the contrary observed in parental and mock-
transfected cells under the same experimental conditions. The
results indicate that Neu2 upregulation per se is su⁄cient to
trigger myoblast di¡erentiation in C2C12 cells.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Cleavage of sialic acids from glycoconjugates is a crucial
event, leading to modulation of cellular functions in several
physiological and pathological processes [1,2]. Alterations in
sialylation levels of glycoconjugates during malignant trans-
formation are associated with the malignant phenotype both
in terms of metastatic potential and invasiveness [3^5]. Siali-
dases cleave terminal K2C3 and K2C6 sialyl linkages of ol-
igosaccharides and glycoproteins and are implicated in biolog-
ical phenomena such as di¡erentiation, proliferation, signal
transduction, and cell surface interactions [6]. Three sialidase
genes (neu1^3) have been cloned so far. They encode for dif-
ferent isoforms with distinct enzymatic properties and sub-
strate speci¢city. Sialidases are characterized by an YRIP mo-
tif in their N-terminus that contains an arginine residue
required for catalysis and several Ser-X-Asp-X-Gly-X-Thr-
Trp repeated sequences (Asp-boxes) with unknown function
[7]. Mammalian sialidases have been classi¢ed on the basis of
their subcellular localization [8] as cytosolic, lysosomal (intra-
lysosomal and membrane-bound), and plasma membrane-
bound. Lysosomal sialidase Neul appears to play a major
role in glycoprotein catabolism by collaborating with lyso-
somal proteases and endoglycosidases [9^11]. Plasma mem-
brane sialidase Neu3 speci¢cally hydrolyzes gangliosides and
might play a role in cell surface events and neuronal di¡er-
entiation [12^14]. The cytosolic sialidase Neu2 is highly ex-
pressed in skeletal muscle [15,16] and at di¡erent levels in liver
[17] and brain [18]. Also, a murine cytosolic sialidase highly
homologous to the muscle protein has been cloned from thy-
mus [19].
Cytosolic sialidase is also capable of desialylating glycopro-
teins and gangliosides at neutral pH, in agreement with the
presence in the cytosol of ganglioside^protein complexes
[20,21]. In the past years, Neu2 has been implicated in the
myotube formation process [22].
During skeletal muscle development multipotent mesoder-
mal precursors commit to a muscle cell fate. This is followed
by myoblast proliferation, withdrawal from the cell cycle, ac-
tivation of muscle-speci¢c genes, and fusion to form multi-
nucleated myotubes [23,24]. In this work we investigated the
biological role of cytosolic sialidase Neu2 during in vitro myo-
blast di¡erentiation in the murine myogenic C2C12 cell line
[25], a favored model to study muscle di¡erentiation. To this
purpose, Neu2 expression was studied both at transcription
and enzymatic levels during di¡erentiation. Also, C2C12 cells
were stably transfected with the rat Neu2 cDNA to determine
the e¡ect of its overexpression on myogenesis.
2. Materials and methods
2.1. Plasmid construction
The ^1415/-5 fragment of the Neu2 rat promoter prior to the ATG
initiation codon [26] was obtained by polymerase chain reaction
(PCR) ampli¢cation of rat genomic DNA using speci¢c primers
with the KpnI adaptor in 5P (sense, 5P-GGGGTACCCC/TTCCT-
GCCTCAGCTTCTCACATGC-3P ; antisense, 5P-GGGGTACCCC/
TGAGATCTGGGCAGAAAGAGAAGAC-3P) under the following
conditions: 95‡C for 2 min, 60‡C for 1 min, 72‡C for 2 min followed
by nine cycles of 94‡C for 30 s, 60‡C for 30 s, 72‡C for 2 min,
followed by 26 cycles of 94‡C for 30 s, 66‡C for 30 s, 72‡C for
2 min. Next, the Neu2 rat promoter was cloned into the KpnI site
of the luciferase reporter expression vector pGL2-Basic (Promega),
thus generating the pGL2-Basic-Neu2 rat promoter vector.
The rat Neu2 sialidase cDNA coding sequence was ampli¢ed from
a PC12 cell cDNA library using speci¢c primers (sense, 5P-CGG-
AATTCCG/ATGGAGACCTGCCCCGTCCTCCAGA-3P ; antisense,
5P-CGGAATTCCG/TCACTGAGCACCATGTACTGTGGGA-3P)
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under the following conditions: 95‡C for 2 min, 59‡C for 1 min, 72‡C
for 3.5 min followed by nine cycles of 94‡C for 30 s, 59‡C for 30 s,
72‡C for 3.5 min, followed by 34 cycles of 94‡C for 30 s, 66‡C for 30 s,
72‡C for 3.5 min. Then, the rat Neu2 cDNA was cloned into the
EcoRI site of pCDNA vector, thus generating the pCDNA-Neu2 ex-
pression vector.
2.2. Cell line, cell staining and stable DNA transfection
The mouse C2C12 myoblasts were cultured at 37‡C (in an atmo-
sphere of 5% CO2) in Dulbecco’s modi¢ed Eagle’s medium with high
glucose (DMEM; Sigma-Aldrich) and supplemented with 10% (v/v)
fetal bovine serum (Sigma-Aldrich) and 100 Wg/ml penicillin/strepto-
mycin (Sigma-Aldrich). This growth medium was designated GM. To
induce di¡erentiation, subcon£uent cells were shifted to DMEM con-
taining 2% horse serum (or 2% horse serum plus bovine insulin, 5 ng/
ml, Sigma-Aldrich) and the medium was changed every day. This
di¡erentiating medium was designated DM or DM plus insulin. To
visualize myotubular structures, cells were washed three times in phos-
phate-bu¡ered saline (PBS) before ¢xing for 10 min in 100% methanol
at 320‡C. Cells were stained with Giemsa reactive (Sigma-Aldrich)
for 2^3 h and again washed in PBS.
To obtain stable Neu2-overexpressing C2C12 myoblasts and the
corresponding mock transfectants, cells (1U105/60 mm dish) were
transfected with pCDNA-Neu2 or pCDNA expression vectors (1 Wg/
dish), respectively, in Fugene reagent (Roche Molecular Biochemicals)
according to the manufacturer’s instructions. Stable transfectants were
cloned after 10^15 days selection in G418 antibiotic (0.5 mg/ml;
Promega).
2.3. Transient transfection assays
Transfections were performed by Fugene reagent. Myoblasts cells
(1 U105/60 mm dish) were transfected with a mix of 1 Wg of pGL2-
Basic-Neu2 promoter expression vector and 10 ng of the transfection
control vector pRL-TK-Renilla luciferase (Promega). Following
transfection, the medium was replaced with DM or GM. Luciferase
activity was measured in the total protein lysates using the Promega
Dual luciferase assay system. Data were corrected for transfec-
tion e⁄ciency by measuring the Renilla luciferase activity according
to manufacturer’s instructions and normalized to 100 Wg of pro-
teins.
2.4. Sialidase assay
Cells were washed with PBS and sonicated at 4‡C in nine volumes of
0.25 M sucrose containing 1 mM EDTA and a mix of protease inhib-
itors (Complete Mini Protease Inhibitors, Roche Molecular Biochem-
icals) for 10 s at an intermediate setting. The mixture was centrifuged at
600Ug for 10 min and the supernatant ultracentrifuged at 105 000Ug
for 60 min at 4‡C. The supernatant was used as the cytosolic fraction
and assayed for sialidase activity. The assay mixture contained 60
nmol of the substrate 4-methylumbelliferyl N-acetylneuraminic acid
(4-MUB-NANA; Sigma-Aldrich), 100 Wg of bovine serum albumin
(BSA) and aliquots of enzyme fractions (50^100 Wg of proteins) in a
¢nal volume of 0.2 ml of 50 mM sodium acetate bu¡er (pH 5.5). After
incubation at 37‡C for 2^3 h, the reaction was terminated by addition
of 0.8 ml of 0.25 M glycine bu¡er (pH 10.4), and the amount of
4-methylumbelliferone released was determined £uorometrically with
an excitation wavelength of 365 nm and emission of 450 nm.
2.5. RNA extraction and reverse transcription (RT)-PCR analysis
Total RNA was obtained as described by Chomczynski and Sacchi
[27]. The pellet of RNA was resuspended in RNAase-free water, di-
gested with 1 unit of DNAase (DNA-free; Ambion) for 1 h at 37‡C
according to the manufacturer’s instructions. 2 Wg of total RNA was
retrotranscribed with 400 units of Moloney murine leukemia virus
reverse transcriptase (Promega) for 1 h at 37‡C, and the RT template
was used for PCR ampli¢cation. For RT-PCR analysis of murine
cytosolic Neu2 sialidase expression, primers 5P-CGAGCCAGCAA-
GACGGATGAG-3P (sense) and 5P-GGCTCTACAAGCTTACTCA-
CTACCCGG-3P (antisense) were used under the following condi-
tions: 95‡C for 2 min, 65‡C for 1 min, 72‡C for 1 min followed by
32 cycles of 94‡C for 30 s, 65‡C for 30 s, 72‡C for 1 min. For the
screening of Neu2 transfectants, PCR analysis was performed using
the same primers utilized to clone the rat Neu2 cDNA into its ex-
pression vector in order to avoid ampli¢cation of the endogenous
murine Neu2 mRNA under the following conditions: 95‡C for
2 min, 65‡C for 1 min, 72‡C for 1.5 min followed by 29 cycles of
94‡C for 30 s, 65‡C for 30 s, 72‡C for 1.5 min. For RT-PCR analysis
of glyceraldehyde 3-phosphate dehydrogenase expression, the primers
5P-CGTGGAGTCTCCTGGTGTCTTC-3P (sense) and 5P-GTGAG-
TTGTCATATTTCTTGTGGTT-3P (antisense) were used under the
following conditions: 95‡C for 2 min, 60‡C for 1 min, 72‡C for
Fig. 1. C2C12 myoblast di¡erentiation. A: Morphology of C2C12 cells di¡erentiated in DM for 4 days (panel a) or maintained in GM (panel
b). The cells were photographed under a phase contrast microscope. Note the numerous myotubes in di¡erentiated C2C12 cells (panel a). Bars,
60 Wm. B: Western blot analysis of nuclear extracts of C2C12 cells maintained in DM (panels a and b) or in GM (panels c and d) for 0^72 h.
Nuclear proteins were probed with monoclonal anti-myogenin (panels a and c) and anti-cyclin Dl (panels b and d) antibodies.
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1 min followed by 18 cycles of 94‡C for 30 s, 60‡C for 30 s, 72‡C for
1 min.
2.6. Nuclear extracts and Western blot
For the nuclear extracts, cells were rinsed and harvested with ice-
cold PBS. Cells were centrifuged at 4‡C (800Ug for 10 min), lysed in
lysis bu¡er (500 Wl of ice-cold 10 mM HEPES, pH 7.9, containing 10
mM KCl, 1.5 mM MgCl2, 0.5 mM dithiothreitol (Sigma-Aldrich),
added to protease inhibitor mix, and centrifuged at 800Ug at 4‡C
for 5 min. The pellet was resuspended in 500 Wl of lysis bu¡er with
0.5% NP-40 (Sigma-Aldrich) added, homogenized with a Dounce ho-
mogenizer, and centrifuged at 2500Ug for 5 min at 4‡C. The nuclear
pellet was resuspended in 30 Wl of ice-cold 20 mM HEPES, pH 7.9,
containing 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25%
glycerol, 0.5 mM dithiothreitol and protease inhibitor mix, incubated
on ice for 20 min, and centrifuged at 14 000Ug for 15 min at 4‡C. The
supernatant containing the nuclear proteins was stored at 320‡C.
Protein concentration was assessed by Coomassie assay (Pierce Re-
agent) according to the manufacturer’s instructions. Aliquots (30^50
Wg) of nuclear proteins were analyzed by Western blotting using 1:500
dilution of monoclonal anti-myogenin antibody (mAb F5D, Santa
Cruz Biotechnology) or of anti-cyclin Dl antibody (mAb HD11, Santa
Cruz Biotechnology). Immunocomplexes were visualized using en-
hanced chemiluminescence reagent (Pierce) according to the manufac-
terer’s instructions.
2.7. Immuno£uorescence
C2C12 cells were plated on 12 mm glass coverslips coated with 100
ng/ml poly-L-lysine (Sigma-Aldrich), cultured until 90% con£uency
and then maintained in GM or shifted to DM for the following
days. Cells were ¢xed with ice-cold methanol for 10 min at 320‡C,
washed with PBS and permeabilized with 0.2% Igepal (Sigma-Aldrich)
in PBS containing 5% goat serum (GS) and 2% BSA for 30 min at
room temperature. Cells were then incubated for 2 h in humid atmo-
sphere with monoclonal anti-myogenin antibody (F5D clone, Santa
Cruz Biotechnology) diluted 1:500 in 1% GS/PBS, washed and
mounted with mowiol (Sigma-Aldrich). Fluorescent staining of cells
was observed under an Axiovert S100 microscope (Zeiss). Pictures
were taken with a digital camera (SensiCam) and Image-Pro Plus
software version 4.5.
3. Results
3.1. Sialidase Neu2 expression during C2C12 myoblast
di¡erentiation
The murine myogenic C2C12 cell line di¡erentiates to form
typical myotube structures (Fig. 1A, panel a) when cultured at
con£uence in the presence of a di¡erentiating medium (DM).
In contrast, C2C12 cells retain an undi¡erentiated, proliferat-
ing phenotype when maintained in a growth medium (GM)
(Fig. 1A, panel b). Accordingly, an increase in the nuclear
levels of the transcription factor myogenin, a member of basic
helix loop helix (bHLH) nuclear proteins known to play a
major role during muscle cell fusion [28^30], was observed
in cells grown in DM (Fig. 1B, panel a). This was paralleled
by a dramatic decrease in the levels of cyclin Dl protein (Fig.
1B, panel b), a protein involved in cell cycle progression
[31,32]. By contrast, no increase in the nuclear levels of my-
ogenin was observed in C2C12 cells maintained in GM (Fig.
1B, panel c) that also retained high levels of expression of
cyclin Dl protein (Fig. 1B, panel d). On this basis, Neu2
mRNA expression was investigated by semi-quantitative
RT-PCR analysis during myotube formation. As shown in
Fig. 2A, a rapid, long-lasting increase of Neu2 transcript
steady-state levels was observed in C2C12 cells grown in
DM. Accordingly, a prolonged signi¢cant increase of sialidase
activity was detectable in the cytosolic fraction of di¡erentiat-
ing C2C12 cells (Fig. 2B).
To assess whether the induction of Neu2 expression oc-
curred, at least in part, at the transcriptional level, C2C12
cells were transiently transfected with the luciferase reporter
gene under the control of the rat Neu2 promoter [26]. After
24 h, cells were given GM, DM, or DM plus insulin (a hor-
mone growth factor that enhances myoblast di¡erentiation
Fig. 2. Neu2 expression in di¡erentiating C2C12 cells. A: C2C12 cells were cultured in DM for the indicated periods of time and Neu2 tran-
script expression was investigated by RT-PCR analysis using gapdh transcript as a control. B: Time course of enzymatic Neu2 sialidase activity
in C2C12 cells maintained in DM. Cytosoluble Neu2 activity was determined using 4-MUB-NANA as substrate. The values are the average of
three independent experiments. C: Transcriptional induction of Neu2 promoter in di¡erentiating C2C12 cells. Cells were transiently transfected
with the pGL2-Basic-Neu2 promoter expression vector harboring the luciferase reporter gene under the control of the rat Neu2 promoter. The
day after, cells were harvested and seeded in 6 cm plates (1.5U1O5 cells/dish) in GM, DM, or DM plus insulin. After 24 h, luciferase activity
in the cell extracts was measured and normalized for protein content. Statistical analysis was performed by Student’s t-test (n=3 for each
group). *P6 0.05.
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[33]). The results demonstrate a V2.2-fold induction of lucif-
erase activity in cells grown in DM when compared to undif-
ferentiated cells grown in GM. Such an increase was even
higher (Vthree-fold) in cells grown in DM plus insulin (Fig.
2C).
3.2. Neu2 overexpression induces myoblast di¡erentiation in
C2C12 cells
To assess the biological signi¢cance of Neu2 upregulation
in myoblast di¡erentiation, C2C12 cells were stably trans-
fected with an expression vector harboring the rat sialidase
Neu2 cDNA. After selection, several resistant clones were
obtained and investigated for rat Neu2 expression by semi-
quantitative RT-PCR analysis, using speci¢c primers for the
transgene. Also, the clones were tested for sialidase activity in
the cytosoluble fraction of cellular lysates. As shown in Fig.
3A, all the clones tested express rat Neu2 mRNA, even
though to a di¡erent extent, whereas no expression was ob-
served in parental and mock-transfected cells. The sialidase
activity in the cytosolic fraction strictly correlated with the
di¡erent expression levels of the corresponding rat Neu2 tran-
script (Fig. 3A).
All the Neu2 transfectants were characterized by a signi¢-
cant decrease in the growth rate when compared to parental
and mock cells (Fig. 3B). Moreover, all the transfectants
showed the capacity to form myotubes also when maintained
in GM (Fig. 4A, panel a). This capacity was absent in mock-
transfected cells (Fig. 4A, panel c). Thus, Neu2 overexpression
appears to be able to induce myogenesis in C2C12 cells also
under non-di¡erentiating cell culture conditions. Accordingly,
Neu2 transfectants grown in GM were characterized by high
levels of myogenin protein and by the sustained downregula-
tion of cyclin Dl protein levels when compared to mock cells,
as evidenced by Western blot analysis of the nuclear extracts
(Fig. 4B). The immunostaining for myogenin in Neu2 trans-
fectant (Fig. 4A, panel b) and in mock cells (Fig. 4A, panel d)
con¢rmed Western blot analysis.
When grown in DM, the Neu2 transfectants formed multi-
giant hypertrophic myotubes with an elongated morphology,
signi¢cantly larger in size with respect to those observed when
the cells were grown in GM or in parental C2C12 cells main-
tained in DM (Fig. 4C). Again, this was paralleled by a sig-
ni¢cant myogenin upregulation and cyclin Dl downregulation
of the corresponding protein levels in the nuclear extracts
(data not shown).
Finally, Neu2-overexpressing clones grown in GM were
characterized by an increased luciferase activity driven by
the rat Neu2 promoter when compared to parental or mock
cells (Fig. 4D). This indicates that, as observed in di¡erentiat-
ing parental C2C12 cells given DM (see Fig. 2C), also myo-
blast di¡erentiation induced by exogenous Neu2 overexpres-
sion is paralleled by an increase in basal luciferase gene
transactivation.
4. Discussion
In this study we investigated the role of cytosolic sialidase
Neu2 during in vitro myoblast di¡erentiation using murine
C2C12 cells as a model. Di¡erentiating conditions induce
the withdrawal of C2C12 cells from the cell cycle, as shown
by cyclin Dl downregulation, with the activation of the skel-
etal muscle di¡erentiation program characterized by myoge-
nin upregulation and multinucleated myotube formation.
This process was paralleled by the increase of expression of
sialidase Neu2, as observed both at mRNA and enzymatic
activity levels. The transcriptional induction of Neu2 was con-
¢rmed by transient transfection of di¡erentiating C2C12 cells
with an expression vector harboring the luciferase reporter
gene under the control of the rat Neu2 [26]. Interestingly,
analysis of the rat Neu2 promoter has shown the presence
of several canonical and non-canonical E-box sequences that
represent binding motifs for the bHLH factors involved in
skeletal muscle maturation [29]. Moreover, putative sites for
myogenin and MEF-2 transcription factors [34,35], both in-
volved in the di¡erentiation process, are also present (data not
shown).
In order to better understand the importance of Neu2 up-
regulation in myoblast di¡erentiation, stable Neu2 C2C12
transfectants were obtained. Analysis of the Neu2-overex-
pressing clones demonstrated that Neu2 upregulation was fol-
lowed by the acquisition of a di¡erentiated phenotype also
when cells were maintained in the absence of di¡erentiating
conditions (DM). This was demonstrated by a decrease in the
proliferation rate of the transfectants, paralleled by cyclin Dl
Fig. 3. Neu2 overexpression in C2C12 cells. A: Cells were stably transfected with the pCDNA-Neu2 expression vector harboring the rat Neu2
cDNA. After selection, transfectants were compared to parental and mock-transfected cells for rat Neu2 expression by RT-PCR analysis, using
gapdh as a control. In parallel, cells were also tested for cytosolic Neu2 sialidase activity. B: Kinetics of proliferation of Neu2 transfectants.
Parental, mock, and Neu2-7, Neu2-24, and Neu2-29 cell transfectants were seeded at 50 000 cells/60 mm-dish in GM. Cells were counted after
24^96 h. The results are the mean of three independent experiments.
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downregulation, and by the simultaneous expression of myo-
genin and myotube formation. Similar results were obtained
in C2C12 cell cultures transiently transfected with the same
expression vector (data not shown), thus con¢rming the re-
sults obtained in the stable transfection experiments. In con-
trast, no di¡erence in the di¡erentiation was observed in
mock-transfected cells when compared to parental cells.
As observed in parental C2C12 cells shifted to the di¡er-
entiating medium, also di¡erentiating Neu2-overexpressing
clones were characterized by an increased transcriptional ac-
tivity of the transiently transfected rat Neu2 promoter. Taken
together, our data suggest that Neu2 upregulation is tightly
linked to the skeletal muscle maturation process and that an
increase in the cytosolic sialidase activity per se is su⁄cient to
trigger myoblast withdrawal from the cell cycle and the acti-
vation of the myotube formation program. In keeping with
this hypothesis, Neu2 transfectants grown in di¡erentiating
medium formed multi-giant hypertrophic myotubes with an
elongated morphology, signi¢cantly larger in size with respect
to myotubes originating from parental C2C12 cells. These
data extend previous observations on rat L6 myoblast in
which myotube formation was prevented by treatment with
Neu2 antisense oligonucleotides [22].
Previous observations had shown that in vitro myotube
formation is paralleled by changes in glycosphingolipid me-
tabolism [36]. These ¢ndings, together with our observations,
raise the hypothesis that the catabolism of some endogenous
gangliosides may represent an early key step in skeletal muscle
maturation. Gangliosides and glycoproteins are indeed ex-
pected to be present in the cytosol [20,21] and the capacity
Fig. 4. Spontaneous myoblast di¡erentiation of Neu2 transfectants. A: Di¡erentiation of Neu2-overexpressing C2C12 cells (Neu2-7 clone) (pan-
els a and b) and mock-transfected cells (panels c and d) after 6 days at con£uence in GM. Cells were stained with Giemsa reactive (panels a
and c) or immunostained with anti-myogenin antibody (panels b and d). The Neu2 transfectants form well-de¢ned myogenin-positive myotubes,
whereas the mock clone retains an undi¡erentiated morphology. Bars, 60 Wm. B: Western blot analysis of nuclear extracts of Neu2-7 clone and
mock clone maintained in GM for 0^72 h. Nuclear proteins were probed with monoclonal anti-myogenin and anti-cyclin Dl antibodies.
C: Morphology of C2C12 cells grown for 4 days in GM (panel a) or DM (panel b) compared to Neu2-7 transfectants maintained in DM (pan-
el c). The Neu2-7 transfectants form multi-giant hyperthrophic myotubes. Bars, 60 Wm. D: Parental, mock and Neu2-overexpressing Neu2-7
and Neu2-28 clones were transiently transfected with the pGL2-Basic-Neu2 promoter expression vector harboring the luciferase reporter gene
under the control of the rat Neu2 promoter. After 24 h in GM, luciferase activity in the cell extracts was measured and normalized for protein
content (n=4 for each group). *P6 0.01.
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of Neu2 sialidase to work at neutral pH makes these cytosolic
components potential targets for cytosolic sialidase activity.
Indeed, the association of glycosphingolipids to the cyto-
skeleton in di¡erent cell types, including muscle cells, has been
demonstrated [37,38]. In particular GM3, the major ganglio-
side synthesized by myoblasts [39,40], might be a candidate
substrate for cytosolic sialidase [41,42]. The modulation of
endogenous GM3, that interacts with vimentin intermediate
¢laments [38], may represent an initial step in the cytoskeleton
remodeling prior to cell fusion and may therefore represent a
fundamental signal for triggering myoblast di¡erentiation. In
keeping with this hypothesis, Neu2 overexpression has been
shown to modulate melanoma cell invasiveness and migration,
two processes strictly linked to cytoskeleton functions,
through a mechanism involving GM3 hydrolysis [3].
In conclusion, our data demonstrate that cytosolic sialidase
Neu2 upregulation plays a crucial role in skeletal muscle mat-
uration in vitro by controlling the decision between growth
and di¡erentiation. This sheds new light on the molecular
mechanisms that control muscle cell growth and di¡erentia-
tion during embryonic development and regeneration through
satellite cell recruitment in the adult. Also, Neu2 transduction
via gene transfer may have therapeutic implications in the
control of rhabdomyosarcoma tumor cells that arise from
immature mesenchimal cells committed to skeletal muscle lin-
eage with interrupted myogenesis [43,44].
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